The implanted glucose monitoring system Eversense: An alternative for diabetes patients with isobornyl acrylate allergy
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background: Some patients with diabetes develop skin reactions when using systems for continuous glucose monitoring (CGM) or insulin pumps. Regular usage and long wearing periods lead not only to skin irritation, but also to allergic contact dermatitis. It has been shown that allergens such as isobornyl acrylate (IBOA) are present in the plastic housing and also in the adhesives of medical devices used for diabetes treatment. Objectives: To evaluate the IBOA content of all parts of a newly introduced, implanted CGM system (Eversense) to check whether this can be an alternative for IBOA‐sensitized patients. Methods: The IBOA content of the implanted sensor itself (n = 3), the transmitter (n = 3), and two different types of adhesive (white adhesive [n = 4] and clear adhesive [n = 4]) was measured by gas chromatography/mass spectrometry. Results: No IBOA was found in any part of this CGM system. Conclusions: Patients with an IBOA allergy may be able to use this implanted CGM system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Herman, A., Aerts, O., Baeck, M., Bruze, M., De Block, C., Goossens, A., Hamnerius, N., Huygens, S., Maiter, D., Tennstedt, D., et al. (2017) · Contact Dermatitis · doi:10.1111/cod.12866 · Cited by 192
Berg, A. K., Nørgaard, K., Thyssen, J. P., Zachariae, C., Hommel, E., Rytter, K., & Svensson, J. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0088 · Cited by 87 · cited 1×
“In most studies no distinction between skin irritation and ACD has been made.(2,3) A clear classification of skin reactions is not always easy, but efforts to find a plausible guideline to help differentiate between irritant contact dermatitis and ACD are being made.”
BackgroundKamann, S., Aerts, O., & Heinemann, L. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818762946 · Cited by 85 · cited 3×
“The transmitter, which is fixed with one of the two adhesives on top of the skin site where the sensor is implanted, has no direct skin contact, but allergens may be able to diffuse through adhesives.(6,8) Thus, as a precautionary measure, a daily change of the adhesive is recommended.”
BackgroundMethodResultSelf-citationAdhesives Used for Diabetes Medical Devices: A Neglected Risk With Serious Consequences?
Heinemann, L., & Kamann, S. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816662949 · Cited by 74
Self-citationPleus, S., Ulbrich, S., Zschornack, E., Kamann, S., Haug, C., & Freckmann, G. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0171 · Cited by 47 · cited 1×
“A clear classification of skin reactions is not always easy, but efforts to find a plausible guideline to help differentiate between irritant contact dermatitis and ACD are being made.(4) An accurate diagnosis is very important, as it aids in managing the progression of the skin problems and initiating possible therap…”
BackgroundSelf-citation
Cited by
7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s007 · Cited by 358
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
7. Diabetes Technology: Standards of Care in Diabetes — 2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s007 · Cited by 301
7. Diabetes Technology: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s007 · Cited by 281
7. Diabetes Technology: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s007 · Cited by 202
Metadata
- Authors
- Oppel, E., Kamann, S., Heinemann, L., Reichl, F., & Högg, C.
- Venue
- Contact Dermatitis
- Publisher
- Wiley
- Published
- 2019-09-17
- Volume
- 82
- Issue
- 2
- Pages
- 101-104
- ISSN
- 0105-1873 (ISSN-L)
- 1600-0536
- OpenAlex
- W2971102213
- Cited by
- 37
- References
- 5
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.